Related Experiment Video
Updated: Aug 13, 2026
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
[Can IPSS be modified or replaced to evaluate BPH in daily practice?]
1Service d'urologie, CHU Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000 Créteil, France. adelataille@hotmail.com
Annales D'Urologie
|January 24, 2006
Summary
Few doctors utilize the International Prostate Symptom Score (IPSS) for benign prostatic hypertrophy (BPH). Visual Analog Scales (VAS) show promise as a complementary tool for evaluating BPH symptoms and quality of life.
Area of Science:
- Urology
- Medical Diagnostics
Context:
- Benign prostatic hypertrophy (BPH) management guidelines recommend standardized assessment tools.
- Current clinical practice shows limited adoption of the International Prostate Symptom Score (IPSS) for BPH diagnosis and monitoring.
Purpose:
- To review literature on alternative methods for evaluating BPH patients.
- To explore the utility of Visual Analog Scales (VAS) as a complementary tool to IPSS.
Summary:
- A strong correlation exists between IPSS scores and VAS scores for symptom severity, discomfort, and quality of life in BPH patients.
- Symptom improvements following medical treatment are consistently reflected in both IPSS and VAS scores.
- VAS may offer a valuable adjunct for assessing BPH patient outcomes.
Impact:
- Suggests VAS as a potentially valuable tool for BPH assessment, complementing existing methods.
- Highlights the need for further research in broader patient populations before widespread clinical adoption.
- Aims to improve the evaluation and monitoring of patients with benign prostatic hypertrophy.
